These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16877412)

  • 1. Allergic tears promote upregulation of eosinophil adhesion to conjunctival epithelial cells in an ex vivo model: inhibition with olopatadine treatment.
    Cook EB; Stahl JL; Brooks AM; Graziano FM; Barney NP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3423-9. PubMed ID: 16877412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells.
    Cook EB; Stahl JL; Sedgwick JB; Barney NP; Graziano FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):65-72. PubMed ID: 14756467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
    Oh JW; Shin JC; Jang SJ; Lee HB
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells.
    Cook EB; Stahl JL; Barney NP; Graziano FM
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):424-9. PubMed ID: 11730187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G; Ajayi Y; Stern ME; Calder VL
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
    Leonardi A; Jose PJ; Zhan H; Calder VL
    Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A; Quintieri L
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of the upregulation of ICAM-1/VCAM-1 expression of corneal fibroblasts on the pathogenesis of allergic keratopathy.
    Okada N; Fukagawa K; Takano Y; Dogru M; Tsubota K; Fujishima H; Matsumoto K; Nakajima T; Saito H
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4512-8. PubMed ID: 16303942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of conjunctival epithelial cells in chronic ocular allergic disease.
    Hingorani M; Calder VL; Buckley RJ; Lightman SL
    Exp Eye Res; 1998 Nov; 67(5):491-500. PubMed ID: 9878210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
    Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans.
    Leonardi A; Abelson MB
    Clin Ther; 2003 Oct; 25(10):2539-52. PubMed ID: 14667955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear and conjunctival changes during the allergen-induced early- and late-phase responses.
    Bacon AS; Ahluwalia P; Irani AM; Schwartz LB; Holgate ST; Church MK; McGill JI
    J Allergy Clin Immunol; 2000 Nov; 106(5):948-54. PubMed ID: 11080719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model.
    Abelson MB
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):211-8. PubMed ID: 9759796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
    Berdy GJ; Spangler DL; Bensch G; Berdy SS; Brusatti RC
    Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta.
    Godding V; Stark JM; Sedgwick JB; Busse WW
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):555-62. PubMed ID: 7576691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.